Metraipolis › archive › dc_b5926f0b552e
Screening and experimental validation of modified Gandou Decoction-targeted inhibitors for alleviating AD components via network pharmacology, machine… — Europe PMC PMID:41244831
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41244831
- DOI
- 10.3389/fphar.2025.1685866
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T22:04:02.162Z
- SHA-256 of the archived text
b907ce3f3e04dee2b9875de8f09c1550036884d0b231cec6c7ca7cdab12551a3- Stable URL of this page
https://metraipolis.com/documento/dc_b5926f0b552e
How to cite
Screening and experimental validation of modified Gandou Decoction-targeted inhibitors for alleviating AD components via network pharmacology, machine… — Europe PMC PMID:41244831 — Europe PMC (en), https://europepmc.org/article/MED/41244831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5926f0b552e (Metraipolis archive dc_b5926f0b552e, sha256 b907ce3f3e04dee2b9875de8f09c1550036884d0b231cec6c7ca7cdab12551a3)
BibTeX
@misc{dcb5926f0b552e,
title = {Screening and experimental validation of modified Gandou Decoction-targeted inhibitors for alleviating AD components via network pharmacology, machine… — Europe PMC PMID:41244831},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41244831},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5926f0b552e; sha256 b907ce3f3e04dee2b9875de8f09c1550036884d0b231cec6c7ca7cdab12551a3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41244831. Agents can read the archived copy with the MCP tool read_document.